Skip to main content

Table 1 Surgery, pathology, and metastases in patients from group A

From: Cervical masses as manifestation of papillary thyroid carcinomas ≤10 mm in diameter, in patients with unknown thyroid disease

Patient Age Tumor size (mm) Pathology Infiltration/Extension Metastatic lymph nodes Tg ** Metastases * Follow up (mo) Recurrence/persistent disease
PA 50 10 P-f   5 27.6 Upper mediastinum
Lymph nodes
39 CLN
TZ 43 4 P-f Thyr capsule
Thyr parenchyma
2 43.7   51 -
58 8 P-f - 1 59.3   41 -
GM 40 10 & 2 & 2 P-f Thyr capsule
Thyr parenchyma
4 0.4   36 -
MT 57 10 & 2 & 1 P-f Thyr capsule
Thyr parenchyma
7 43.0   75 CLN c
SE 37 4 P - 11 1.9   60 -
KT 34 10 & 2 P Thyr parenchyma
Fatty tissue
3 19.5   140 CLN
KM 26 2 & 5 P - 1 0.8   56 _
AA 56 5 P - 1 25.7   34 CLN
LC 63 1 P-f - 2 0.7   46 -
HD 33 8 P-f Thyr capsule
Thyr parenchyma
3 5.9   48 -
HS 56 10 & 3 & 2 P-f Thyr parenchyma
Fatty tissue
1 3.7   34 -
MD 38 7 P-f - 1 7.7   44 -
TP 32 2 & 10 P - 3 0.5   38 -
SP 37 8 & 10 P Nodule capsule
Fatty tissue
9 503.0 Lower mediastinum
Lymph nodes
58 _
GK 24 7 & 8 P-f - 2 2631.0 Parapharyngeal area 48 _
HI 28 9 P-f - 1 5.3   36 -
ZS 57 10 P Nodule capsule 2 8.7   40 -
KA 21 7 P - 1 2.3   102 -
NG 16 9 P-f Thyr capsule
Thyr parenchyma
3 27.7 Upper mediastinum lymph nodes 56 CLN
PF 26 8 & 9 P-f Thyr capsule
Thyr parenchyma
8 134.0 Upper mediastinum lymph nodes 42 CLN
VA 58 8 & 5 P Thyr parenchyma
Fatty tissue
4 0.3   130 -
AS 42 8 P-f Thyr capsule
Thyr parenchyma
4 791.2   40 CLN
BE 27 5 P-f Thyr capsule
Thyr parenchyma
7 0.3   42  
  1. P: papillary, P-f: Papillary-follicular type, Thyr: Thyroid, CLN: cervical lymph nodes, c: controlateral of initial disease, metastatic lymph nodes, *Postoperative thyroglobulin on stopping LT4, ** Distant metastases diagnosed with the post-therapy WBS